Abstract
Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) are at increased risk for excessive perioperative blood loss requiring transfusion of blood products. Point-of-care evaluation of platelets, coagulation factors, and fibrinogen can enable physicians to assess bleeding abnormalities rapidly. They also can facilitate the optimal administration of pharmacologic and transfusion-based therapy and allow physicians to identify patients with surgical bleeding. The ability to reduce the unnecessary use of blood products in this setting has important implications for emerging issues in blood inventory and blood costs. The ability to decrease operative time along with re-exploration rates has important consequences for health care costs in an increasingly managed health care environment.
Original language | English |
---|---|
Pages (from-to) | 217-228 |
Number of pages | 12 |
Journal | Seminars in Cardiothoracic and Vascular Anesthesia |
Volume | 5 |
Issue number | 3 |
DOIs | |
State | Published - 2001 |